Document is current
Any future updates will be listed below
-
Authors
Grussu, Francesco https://orcid.org/0000-0002-0945-3909
Grigoriou, Athanasios
Bernatowicz, Kinga
Palombo, Marco https://orcid.org/0000-0003-4892-7967
Casanova-Salas, Irene
Navarro-Garcia, Daniel
Barba, Ignasi https://orcid.org/0000-0001-9886-3776
Simonetti, Sara
Serna, Garazi https://orcid.org/0000-0003-2666-0982
Macarro, Carlos https://orcid.org/0009-0000-0597-9316
Voronova, Anna Kira https://orcid.org/0009-0006-9600-0436
Garay, Valezka
Corral, Juan Francisco
Vidorreta, Marta
García-Polo García, Pablo
Merino, Xavier
Mast, Richard
Rosón, Núria
Escobar, Manuel
Vieito, Maria
Toledo, Rodrigo
Nuciforo, Paolo
Mateo, Joaquin
Garralda, Elena
Perez-Lopez, Raquel https://orcid.org/0000-0002-9176-0130
- License Information
-
More Information
Article History
Received: 5 December 2024
Accepted: 5 November 2025
First Online: 20 November 2025
Competing interests
: This study received funding from AstraZeneca. M.Vid. works for Siemens Healthineers. P.G.P.G. works for GE HealthCare. K.B. worked as a researcher at the Vall d’Hebron Institute of Oncology (Barcelona), and is now an employee of AstraZeneca. AstraZeneca, Siemens and General Electric did not influence the acquisition and analysis of the data, the interpretation of the results, or the decision to submit the manuscript in its current form for publication. All other authors declare no competing interests.
